Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 4,078 shares at $71.43 ($293K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($293k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.43 | 757 | $54K | 18.5% |
| 2 | $71.43 | 757 | $54K | 18.5% |
| 3 | $71.44 | 705 | $50K | 17.2% |
| 4 | $71.44 | 705 | $50K | 17.2% |
| 5 | $72.55 | 327 | $24K | 8.1% |
| 6 | $72.66 | 486 |
| $35K |
| 12.1% |
| 7 | $73.43 | 224 | $16K | 5.6% |
| 8 | $73.46 | 117 | $9K | 2.9% |
| Total | $71.84 avg | 4,078 | $293K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |